3M (MMM) Q1 2026 earnings summary

Executive summary

• Q1 2026 sales reached $6.03 billion, up 1.3% year-over-year, with organic growth of 1.2% and double-digit order growth, led by strength in industrial, safety, and electronics segments.

• Adjusted EPS rose 14% year-over-year to $2.14, while GAAP EPS declined 40% to $1.23 due to special items and Solventum share price decline.

• Operating margin improved to 23.8% adjusted (up 30 bps) and 23.2% GAAP (up 230 bps), driven by productivity and cost discipline.

• $2.4 billion was returned to shareholders in Q1 through dividends and share repurchases.

• Transformation initiatives included portfolio reshaping, automation investments, facility consolidation, and new product launches.

Financial highlights

• Adjusted sales grew 1.2% year-over-year to $6.0B; operating income rose to $1.40B, with adjusted operating margin at 23.8%.

• Adjusted free cash flow was $541 million, up 10% year-over-year, and inventory days reduced by three.

• Orders grew over 10%, with backlog up 20% year-over-year and 35% sequentially.

• $2.4 billion returned to shareholders: $0.4 billion in dividends and $2.0 billion in buybacks.

• Cash from operations totaled $574 million, with adjusted net cash from operations at $766 million.

Outlook and guidance

• Full-year 2026 guidance reiterated: organic sales growth ~3%, adjusted EPS $8.50–$8.70, and >100% free cash flow conversion.

• Adjusted operating margin expected to expand by 70–80 bps.

• Q2 organic growth expected above 3% with margin expansion; H2 anticipated to outperform H1.

• Guidance incorporates headwinds from Solventum stranded costs, oil/input cost inflation, and PFAS exit.

• Capital spending for 2026 expected to be ~$1.1 billion, focused on growth, productivity, and sustainability.